ReproCELL Europe Preclinical Drug Trial System

31 July 2020

ReproCELL Europe Preclinical Drug Trial System

ReproCELL Europe’s PM1 instrument provides real-time information on drug potency by measuring changes in the shape and form of isolated blood vessels during a pre-programmed perfusion schedule. Read the ReproCELL Europe Preclinical Drug Trial System case study